Elaine Heron

Track

Insider profile

Currently holds a position at Biomarin Pharmaceutical Inc

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Biomarin Pharmaceutical Inc July 1, 2002 -
Elaine Heron's trades of Palvella Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Vaxart Inc (VXRT)
Transaction date
Purchase
Price
53.72
Quantity 97,054 -12.1%
Value US$1,579,479
US Vaxart Inc (VXRT)
Transaction date
Purchase
Price
335.48
Quantity 57,698 -7.4%
Value US$3,460,878
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-02 2026-02-27
B Purchase
19,426 -8.8%
290.56
US$4,712,075 		19,426 -8.8% 290.56 US$4,712,075
2025-11-21 2025-11-17
US Vaxart Inc (VXRT)
B Purchase
97,054 -12.1%
53.72
US$1,579,479 		97,054 -12.1% 53.72 US$1,579,479
2025-11-21 2025-11-17
US Vaxart Inc (VXRT)
B Purchase
57,698 -7.4%
335.48
US$3,460,878 		57,698 -7.4% 335.48 US$3,460,878